Search

everythinglearnresearchcommunity

for

Search:↓

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

Resveratrol shows health benefits but faces challenges in effectiveness and regulation.

The new delivery system makes retinol and niacinamide more stable and effective for anti-aging and skin-brightening.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Topical dapsone gel reduced flare-ups in folliculitis decalvans without side effects.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Isotretinoin effectively improved severe pityriasis rubra pilaris with complications.

Oral Acitretin effectively resolved symptoms in a child with Netherton syndrome.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Some elderly men had healing problems after using imiquimod and diclofenac for skin conditions on their scalps.

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

The patient quickly recovered from hair loss caused by DRESS syndrome using topical minoxidil.

Hair regrowth improved, but quality of life did not.

Oral isotretinoin is the most effective treatment for folliculitis decalvans.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

ADSC therapy is promising for antiaging skin treatment.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.